The aim was to investigate the psychological consequences of further invest
igation after breast cancer screening. Study participants include 509 women
(61%) recalled due to suspicious findings on screening mammograms, and a m
atched control group of 285 women (68%) with normal mammograms. Psychologic
al distress was prospectively assessed with the Hospital Anxiety and Depres
sion Scale (HADS). 46% of the women reported borderline or clinically signi
ficant anxiety prior to the recall visit. A few days after the visit, anxie
ty and depression had decreased significantly (P < 0.01) in women informed
about normal or benign results at the recall clinic, while reported distres
s remained at relatively high levels in women referred to surgical biopsy.
The results demonstrate the adverse short-term effect of a delay in receivi
ng false-positive results, but do not indicate that the recall experience r
esults in long-term anxiety or depression for a majority of women. <(c)> 20
01 Elsevier Science Ltd. All rights reserved.